Latest:

Fat Pitch Financials

Special situation stocks and value investing

Stock Quote

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Ampio Pharmaceuticals (NY: AMPE )

1.730 USD +0.040 (+2.37%)
Streaming Delayed Price Updated: 7:18 AM EST, Feb 26, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 868
Open 1.690
Bid (Size) 1.720 (10)
Ask (Size) 1.740 (1)
Prev. Close 1.690
Today's Range 1.620 - 1.730
52wk Range 0.3100 - 2.980
Shares Outstanding 86,320,968
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Ampio Pharmaceuticals, Inc. to Report Annual 2020 Financial Results and Provide Corporate Business Update
Ampio Pharmaceuticals (NYSE American: AMPE), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, today announced it will host a... 
From PR Newswire
Ampio Brings New Hospitals Online in Trial for Inhalation Treatment of COVID-19 with Ampion
Additional study sites will accelerate patient enrollment. 
From PR Newswire

Performance

YTD
+16.89%
+16.89%
1 Month
+1.76%
+1.76%
3 Month
+97.69%
+97.69%
6 Month
+148.03%
+148.03%
1 Year
+167.80%
+167.80%

More News

Read More
Penny Stocks To Buy For Under $3 This Week, Are They On Your List?
Tags Market News
From Penny Stocks to Buy, Picks, News and Information | PennyStocks.com - Feed
Ampio Pharmaceuticals, Inc. to Present at Upcoming Investor Conference
From PR Newswire
Ampio Announces Early Positive Data in Phase 1 Trial of Inhaled Ampion in COVID-19 Respiratory Distress
From PR Newswire
Ampio Pharmaceuticals Ongoing Phase I Clinical Trial for Inhalation Treatment of COVID-19 with Ampion is 55% Enrolled
From PR Newswire
Ampio Provides Update on Clinical Trials for Ampion™ Treatment of COVID-19 Patients
From PR Newswire
Ampio Receives feedback from the FDA on Ampio's Proposed Modifications to the special protocol assessment for Ampion treatment of severe Osteoarthritis of the knee
From PR Newswire
Thinking about buying stock in Ampio Pharmaceuticals, Motus GI, Phio Pharmaceuticals, Novan, or Oncolytics Biotech?
From PR Newswire
A Specialty Consolidator: Biopharma Aytu Looks To Acquisitions And Licensing To Propel Growth Through 2021
Tags General ABBV SNY
From Benzinga
GameStopped
Tags Options Stocks / Equities Services
From Blogs - TalkMarkets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.